Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Genex Services Expands IME Services Through ECN Acquisition
National company extends Genex IME platform for non-occupational disability and automobile insurance markets WAYNE, PA - January
PDF
News Release
Press Release - Coventry Acrometis Partnership
Workers' Comp
News Release
Coventry and Acrometis Form Data-and-Technology Partnership to Drive Efficiency
DOWNERS GROVE, Ill. (Jan.
PDF
Article
WC Magazine: The New Cost of Mistaken Identity
Are Your Workers’ Comp Partners Misclassifying Their Independent Contractors? A recent WC Magazine article, "The New Cost of Mistaken I
Workers' Comp
Article
Property Casualty 360: Establishing a quality IME process for your workers' comp claims
Complex case disputes can result in significant medical and indemnity costs despite efforts to fairly cover the injured worker's medical care and f
Workers' Comp
White Paper
Telemedicine - Telehealth
Technology Tools for Enhanced Clinical Support What is telemedicine?